Panax quinquefolium saponins attenuates microglia activation following acute cerebral ischemia‐reperfusion injury via Nrf2/miR‐103‐3p/TANK pathway

Abstract

AbstractIschemic stroke is one of the leading causes of death and disability among adults worldwide. Intravenous thrombolysis is the only approved pharmacological treatment for acute ischemic stroke. However, reperfusion by thrombolysis will lead to the rapid activation of microglia cells which induces interferon‐inflammatory response in the ischemic brain tissues. Panax quinquefolium saponins (PQS) has been proven to be effective in acute ischemic stroke, but there is no unified understanding about its specific mechanism. Here, we will report for the first time that PQS can significantly inhibit the activation of microglia cells in cerebral of MCAO rats via activation of Nrf2/miR‐103‐3p/TANK axis. Our results showed that PQS can directly bind to Nrf2 protein and inhibit its ubiquitination, which result in the indirectly enhancing the expression of TANK protein via transcriptional regulation on miR‐103‐3p, and finally to suppress the nuclear factor kappa‐B dominated rapid activation of microglial cells induced by oxygen–glucose deprivation/reoxygenation  vitro and cerebral ischemia‐reperfusion injury in vivo. In conclusion, our study not only revealed the new mechanism of PQS in protecting against the inflammatory activation of microglia cells caused by cerebral ischemia‐reperfusion injury, but also suggested that Nrf2 is a potential target for development of new drugs of ischemic stroke. More importantly, our study also reminded that miR‐103‐3p might be used as a prognostic biomarker for patients with ischemic stroke.